Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature.

Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature.
复制标题

阿片类药物使用障碍治疗的障碍:对社交媒体的自我报告信息与文献中发现的障碍的比较。

DOI:
10.3389/fpubh.2023.1141093
复制
发表时间:
2023
影响因子:
5.2
通讯作者:
Sarker, Abeed
Sarker, Abeed
中科院分区:
医学3区
文献类型:
--
作者:
Bremer, Whitney;Plaisance, Karma;Walker, Drew;Bonn, Matthew;Love, Jennifer S.;Perrone, Jeanmarie;Sarker, Abeed

文献摘要

参考文献

相似文献

丁丙诺啡和美沙酮等药物可有效治疗阿片类药物使用障碍(OUD),但许多患者面临与治疗和获取相关的障碍。我们分析了两个数据来源-社交媒体和出版的文献-对这些障碍进行分类和量化。在这项混合方法研究中,我们分析了来自三个OUD相关论坛(subreddits)的社交媒体(Reddit)帖子:r/suboxone,r/美沙酮和r/naloxone。我们应用自然语言处理来识别与治疗障碍相关的帖子,将其分类为保险相关和非保险相关,并手动将其细分为细粒度的主题。为了进行比较,我们使用了物质使用,OUD和障碍相关的关键词来识别2006年至2022年期间发表的PubMed中的相关文章。我们检索了出版物中表达对障碍的恐惧,以及由于障碍而对药物治疗犹豫不决或不感兴趣的语言,特别关注所描述的受影响人群。在社交媒体上,前三位与保险相关的障碍包括没有保险(22.5%),保险不包括OUD治疗(24.7%)和使用保险进行OUD治疗的一般困难(38.2%);而前两位与保险相关的障碍包括耻辱(47.6%)和经济困难(26.2%)。对于已发表的文献,污名是最突出的障碍,发生在78.9%的综述出版物中,其次是接受药物治疗的财务和/或后勤问题(73.7%),性别特异性障碍(36.8%)和恐惧(31.5%)。与OUD和/或寻求治疗和保险/费用相关的耻辱是两个来源中报告的两种最常见的障碍类型。利用多个数据源可使解决恢复障碍的伤害减少工作受益。
Medications such as buprenorphine and methadone are effective for treating opioid use disorder (OUD), but many patients face barriers related to treatment and access. We analyzed two sources of data—social media and published literature—to categorize and quantify such barriers. In this mixed methods study, we analyzed social media (Reddit) posts from three OUD-related forums (subreddits): r/suboxone, r/Methadone, and r/naltrexone. We applied natural language processing to identify posts relevant to treatment barriers, categorized them into insurance- and non-insurance-related, and manually subcategorized them into fine-grained topics. For comparison, we used substance use-, OUD- and barrier-related keywords to identify relevant articles from PubMed published between 2006 and 2022. We searched publications for language expressing fear of barriers, and hesitation or disinterest in medication treatment because of barriers, paying particular attention to the affected population groups described. On social media, the top three insurance-related barriers included having no insurance (22.5%), insurance not covering OUD treatment (24.7%), and general difficulties of using insurance for OUD treatment (38.2%); while the top two non-insurance-related barriers included stigma (47.6%), and financial difficulties (26.2%). For published literature, stigma was the most prominently reported barrier, occurring in 78.9% of the publications reviewed, followed by financial and/or logistical issues to receiving medication treatment (73.7%), gender-specific barriers (36.8%), and fear (31.5%). The stigma associated with OUD and/or seeking treatment and insurance/cost are the two most common types of barriers reported in the two sources combined. Harm reduction efforts addressing barriers to recovery may benefit from leveraging multiple data sources.
DOI: 10.1016/j.drugpo.2020.102769
发表时间: 2020-06-01
影响因子: 4.4
作者:
Ivsins, Andrew;Boyd, Jade;McNeil, Ryan
通讯作者: McNeil, Ryan
DOI: 10.1016/j.drugalcdep.2020.108202
发表时间: 2020-11-01
影响因子: 4.2
作者:
Ivsins, Andrew;Boyd, Jade;McNeil, Ryan
通讯作者: McNeil, Ryan
DOI: 10.1016/j.drugalcdep.2021.108672
发表时间: 2021-05-01
影响因子: 4.2
作者:
Bunting AM;Frank D;Arshonsky J;Bragg MA;Friedman SR;Krawczyk N
通讯作者: Krawczyk N
DOI: 10.1186/s12911-021-01394-0
发表时间: 2021-01-26
影响因子: 3.5
作者:
Al-Garadi MA;Yang YC;Cai H;Ruan Y;O'Connor K;Graciela GH;Perrone J;Sarker A
通讯作者: Sarker A
DOI: 10.1016/j.drugalcdep.2022.109380
发表时间: 2022-04-01
影响因子: 4.2
作者:
Friedman, Joseph;Montero, Fernando;Bourgois, Phillippe;Wahbi, Rafik;Dye, Daniel;Goodman-Meza, David;Shover, Chelsea
通讯作者: Shover, Chelsea